ArticleAmerican journal of respiratory and critical care medicine2024
Spatial Transcriptomics Resolve an Emphysema-Specific Lymphoid Follicle B Cell Signature in Chronic Obstructive Pulmonary Disease.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 35 citations in OpenAlex.
- Preclinical models of COPD: a state of the art review.The European respiratory journal · 2026Review
- Integrated Bioinformatics and Experimental Validation to Identify Shared Sialylation-Related Signatures in Emphysematous and Fibrotic Lung Disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
- Pyroptosis in chronic obstructive pulmonary disease: Beyond the canonical NLRP3/Caspase-1/GSDMD pathway.Immunologic research · 2026Review
- Spatial transcriptomics reveals airway remodelling and molecular targets across COPD severity.ERJ open research · 2026Article
- ERS Congress 2025: highlights from the Basic and Translational Sciences Assembly.ERJ open research · 2026Article
- Defective alveolar regeneration in emphysema: identifying dysfunctional cellular crosstalk and novel therapeutic opportunities for tissue repair.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Spatial transcriptomics reveals compartment-specific cytotoxic T cell crosstalk with AT2 and goblet cells in advanced COPD.Biomarker research · 2026Article
- Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026Review
- From Inflammation to Precision Medicine: Mechanistic Insights into Asthma, COPD, and IPF.Biomedicines · 2026Review
- B1 cells drive pulmonary emphysema progression through ADAM10.Respiratory research · 2026Article
- Unknotting the crosstalk between COPD and neuroinflammation.Journal of neuroinflammation · 2026Review
- New approaches to uncover COPD pathobiology and develop therapies.JCI insight · 2026Review
- Aberrant cellular communities underlying disease heterogeneity in chronic obstructive pulmonary disease.Nature genetics · 2026Article
- From clinical phenotypes to cellular mechanisms: a precision medicine framework for COPD.Frontiers in immunology · 2026Review
- Oxidative stress-driven epigenetic reprogramming of immune cells in COPD: from epitranscriptomic and metabolic crosstalk to treatable traits.Frontiers in immunology · 2026Review
- Multi-omics to study chronic respiratory diseases and viral infections.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Immune-metabolic positive feedback model in COPD: cross-mechanisms and potential intervention strategies.Frontiers in cell and developmental biology · 2026Review
- COPD-Lung Cancer Comorbidity: Mechanistic Insights and Precision Oncology Implications.International journal of chronic obstructive pulmonary disease · 2026Review
- From Web to Collapse: Small Airway Disease Trajectory in Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2025Article
- Spatial single-cell atlas reveals regional variations in healthy and diseased human lung.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 8 institutions in 2 countries.
Joselyn Rojas-QuinteroPulmonary Division, Department of Medicine, and.
Scott A OchsnerDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Felicia NewSpatial Data Analysis Services, Nanostring Biotechnologies, Seattle, Washington.
Prajan DivakarSpatial Data Analysis Services, Nanostring Biotechnologies, Seattle, Washington.
Chen Xi YangCenter for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.
Tianshi David WuPulmonary Division, Department of Medicine, and.
Jerid RobinsonField Application Scientists, Nanostring Biotechnologies, Seattle, Washington.
Darshan Shimoga ChandrashekarPathology, Division of Genomic Diagnostics & Bioinformatics, and.
Nicholas E BanovichTranslational Genomics Research Institute, Phoenix, Arizona.
Ivan O RosasPulmonary Division, Department of Medicine, and.
Maor SaulerPulmonary and Critical Care Medicine, Yale University, New Haven, Connecticut.
Farrah KheradmandPulmonary Division, Department of Medicine, and.
Amit GaggarPulmonary and Critical Care Medicine, and.
Camilla MargaroliPathology - Division of Cellular and Molecular Pathology, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0003-3952-0778
Raul San Jose EsteparApplied Chest Imaging Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-3677-1996
Neil J McKennaSpatial Data Analysis Services, Nanostring Biotechnologies, Seattle, Washington.
Francesca PolverinoPulmonary Division, Department of Medicine, and.ORCID 0000-0001-9686-5698
Baylor College of Medicine · USNanostring Technologies (United States) · USUniversity of Alabama at Birmingham · USBrigham and Women's Hospital · USMichael E. DeBakey VA Medical Center · USTranslational Genomics Research Institute · USUniversity of British Columbia · CAYale University · US
Funding
B cell-adaptive Immune Profile in Emphysema-predominant COPDR01HL149744 · NHLBI · UNIVERSITY OF ARIZONA · PI POLVERINO, FRANCESCA · 2020 to 2024
$3.4MRole of MIF and CD74 in the pathogenesis of emphysemaR01HL155948 · NHLBI · YALE UNIVERSITY · PI BUCALA, RICHARD J, SAULER, MAOR · 2021 to 2025
$3.4MPrognostic Markers of Emphysema ProgressionR01HL149877 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAN JOSE ESTEPAR, RAUL · 2020 to 2023
$2.8MNHLBI NIH HHS HL149744NHLBI NIH HHS R01 HL149744NHLBI NIH HHS R01 HL149877NHLBI NIH HHS R01 HL155948
Abstract
PubMed holds no abstract for this paper.
Indexed as
EmphysemaLymphadenopathyPulmonary Disease, Chronic ObstructivePulmonary EmphysemaGene Expression ProfilingHumansProteomicsautoimmunitycentrilobular emphysemalymphoid folliclesmetabolic reprogrammingswitch-class recombination
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.